G

Gastro-Intestinal Research Foundation

13 employees

For more than 50 years, we have devoted ourselves to making life better for patients and families living with digestive diseases.

Investor insights

Sectors invested in

Biotechnology2

Health Care2

Liquid Biopsy1

Therapeutics1

Pharmaceutical1

Medical1

Health Diagnostics1

Medical Device1

oncology1

tissue IF and H&E imaging1

Circulating Tumor Cell Research1

Non-Invasive Prenatal Testing Research1

cell and gene therapy1

tissue micro-region retrieval1

spatial biology1

IF microscopy1

Rare Cell Analysis1

Single cell analysis1

clinical trials1

Biomarkers1

Funding rounds participated in

$2.8M sweet spot round size

Most of their 2 investments are in rounds between $2.8M and $2.8M

Basic info

Industry

fundraising

Sectors

Biotechnology

Health Care

Date founded

1961

Investments made

R

RareCyte, Inc. raised undisclosed on November 3, 2022

Investors: Gastro-Intestinal Research Foundation

E

Elicio Therapeutics raised $2.8M on November 3, 2022